CD40 Agonist, Flt3 Ligand, and Chemotherapy in HER2 Negative Breast Cancer
Clinical trial NCT05029999 · RECRUITING
Trial details
- NCT number
- NCT05029999
- Sponsor
- University of Texas Southwestern Medical Center
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-04-20
- Primary completion
- 2028-04-20
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.